Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

A Complex Phenotype in an Adult with Recurrent Syncope

Author:Bansal, Dhruv   Kearney, Seamus   

Session Name:P8: Movement Disorders: Rare Movement Disorders  

Topic:Movement Disorders  

Program Number:P8.020  

Author Institution:Royal Victoria Hospital, Belfast, Belfast, United Kingdom  

Trends in the Incidence and Prevalence of Multiple Sclerosis in Pakistan from 1990 to 2021: A Secondary Analysis of the Global Burden of Disease Study

Author:Inam, Syed   Nadeem, Zain   Butt, Mahad   Ashraf, Hamza   Fatima, Eeshal   Nadeem, Aimen   Ashfaq, Haider   Raza, Ahmed   Ahmed, Sophia   Ross, Madelyn   

Session Name:P9: Multiple Sclerosis: Epidemiology and MS in Special Populations 1  

Topic:Multiple Sclerosis  

Program Number:P9.001  

Author Institution:Marshall Neurology, Huntington, WV  Allama Iqbal Medical College, Lahore, Pakistan  Services Institute of Medical Sciences, Daska, Pakistan  King Edward Medical University, Lahore, Pakistan  Services Institute of Medical Sciences, Lahore, Pakistan  Marshall University Joan C Edwards School of Medicine, Huntington, WV  

Stroke Etiology Prediction Utilizing GPT-4

Author:Vasireddy, Sujith   Lee, Jung-Hyun   Angulo Castro, Sergio   McDougal, Robert   Lytton, William   Levine, Steven   

Session Name:P9: Cerebrovascular Disease and Interventional Neurology: Translational Science, Advanced Diagnostics, and Prediction Modeling  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P9.002  

Author Institution:SUNY Downstate, Brooklyn, NY  Kings County Hospital, Brooklyn, NY  Yale School of Medicine, Hamden, CT  

EEG Slowing Increases the Risk of Future Dementia: A Population-Based Cohort Study

Author:Otaiku, Abidemi   Scott, Gregory   Sharp, David   

Session Name:P9: Aging, Dementia, and Behavioral Neurology: Non-AD Dementia Diagnostics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P9.003  

Author Institution:Imperial College London, London, United Kingdom  

Time to First and Sustained Improvement in Weekly Migraine Days Among Patients Receiving Preventive Treatment With Rimegepant 75 mg

Author:Tepper, Stewart   Abraham, Lucy   Bushmakin, Andrew   Cappelleri, Joseph   Fullerton, Terence   Yang, Jiyue   Lipton, Richard   

Session Name:P9: Headache: Advances in CGRP Inhibitors and Migraine 2  

Topic:Headache  

Program Number:P9.005  

Author Institution:New England Institute for Neurology and Headache, Stamford, CT  Pfizer R&D UK Ltd, Tadworth, United Kingdom  Pfizer Inc, Groton, CT  Pfizer Inc, New York, NY  Montefiore Headache Center and the Albert Einstein College of Medicine, New York, NY